Chi2gel

Company Overview

Snapshot

Founded in July 2008, Chi2gel operated with 1–10 employees. The company raised $658,000 across one funding round from one investor. In September 2010, Chi2gel secured seed funding from Ofakim Hi-Tech Ventures.

Business overview

Chi2gel is a development-stage company focused on creating hydrogel-based devices for orthopedics and rheumatology. Its proprietary hybrid hydrogel technology is designed to revitalize degenerated spinal discs and treat painful knee osteoarthritis. The company's product pipeline includes Chi2Knee for intra-articular injection as a viscosupplement and Chi2Disc for lower back pain related to degenerative disc disease, to be used with a disc-restorative device. Chi2gel operates within the Health Tech & Life Sciences sector, specifically targeting Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

What is Chi2gel's primary focus?

Chi2gel is a development-stage company focused on developing hydrogel-based devices for orthopedics and rheumatology, with an initial focus on revitalizing degenerated spinal discs and treating knee osteoarthritis.

When was Chi2gel founded?

Chi2gel was founded in July 2008.

What is Chi2gel's employee count?

Chi2gel operates with 1–10 employees.

What is the status of Chi2gel?

Chi2gel is currently non-active and ceased to operate in May 2019.